Dantari is a Los Angeles area biotechnology company committed to creating breakthrough medicines for the treatment of cancer and other serious diseases.

Using our proprietary platform technology, we have engineered biocompatible polymers that enable targeted delivery of large- and/or small-molecule therapeutics to treat diseases with unmet medical needs.

Our targeting platform provides significantly enhanced capabilities for delivery of therapeutics, including targeting the Blood Brain Barrier to treat cancer or diseases in the CNS. The platform also provides differential release kinetics of small-molecule payloads to optimize delivery of the therapeutics.

Dantari scientists are rapidly advancing these therapies to provide meaningful medical improvement for patients.